Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trimaran Capital Partners is a New York-based private equity and asset management firm, not a life sciences operating company. The firm focuses on middle-market private equity investments and has also managed affiliated credit, CLO, hedge fund, and other investment vehicles. Its investment interests have spanned sectors such as business services, financial services, energy, healthcare services, manufacturing, media, and consumer-related industries, but it does not itself develop therapeutics or medical products. For biotech analysts, Trimaran is best understood as a financial sponsor/investor that may back healthcare-related companies rather than a biotech, pharma, or healthcare operator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trimaran Capital Partners.